Pharmacology and Vitreoretinal Surgery

Preface: Gandorfer, A.; Pharmacologic Vitreolysis; Objective of Pharmacologic Vitreolysis: Gandorfer, A.; Vitreous as a Substrate for Vitreolysis: Bishop, P.N.; Hyaluronidase for Pharmacologic Vitreolysis: Kuppermann, B.; Narayanan R.; Microplasmin-Assisted Vitrectomy: Gandorfer, A.; Pharmacologic Vitreodynamics and Molecular Flux: Goldenberg, D.T; Trese, M.T.; Proliferative Vitreoretinopathy; Glial Cell Changes of the Human Retina in Proliferative Vitreoretinopathy: Wickham, L.; Charteris, D.G.; Alkylphosphocholines: A New Approach to Inhibit Cell Proliferation in Proliferative Vitreoretinopathy: Eibl, K.H.; Fisher, S.K.; Lewis, G.P.; Diabetic Retinopathy and Diabetic Macular Edema; Neuroprotection for Diabetic Retinopathy: Imai, H.; Singh, R:S:J.; Fort, P.E.; Gardner, T.W.; VEGF Inhibitors and Vitrectomy for Diabetic Vitreoretinopathy: Cury, C.E., Jr.; Rodrigues, E.B.; Meyer, C.H.; Farah, M.E.; Age-Related Macular Degeneration; Tissue Plasminogen Activator-Assisted Vitrectomy: Surgical Drainage of Submacular Hemorrhage: Kamei, M; Tano, Y.; Retinopathy of Prematurity; Anti-Angiogenic Therapy in the Management of Retinopathy of Prematurity: Drenser, K.A.; Author Index; Subject Index.